ERBB2 and breast carcinoma: Another interesting possibility is liquid biopsy of cerebrospinal fluid to identify the exact molecular alterations of BCBM cells (122), as it is well known that metastatic breast cancer cells can change their molecular features during invasion and metastasis formation, for instance, in the case of HER2 amplification.